Raleigh Capital Management Inc. Has $73,000 Holdings in Palantir Technologies Inc. (NYSE:PLTR)

Raleigh Capital Management Inc. increased its position in shares of Palantir Technologies Inc. (NYSE:PLTR) by 211.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,971 shares of the company’s stock after buying an additional 1,339 shares during the quarter. Raleigh Capital Management Inc.’s holdings in Palantir Technologies were worth $73,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in PLTR. Northwest Investment Counselors LLC acquired a new position in Palantir Technologies in the 3rd quarter valued at about $25,000. Summit Securities Group LLC bought a new stake in shares of Palantir Technologies in the second quarter valued at about $25,000. Farmers & Merchants Investments Inc. bought a new position in Palantir Technologies during the second quarter worth about $25,000. West Paces Advisors Inc. raised its position in shares of Palantir Technologies by 110.7% in the first quarter. West Paces Advisors Inc. now owns 1,180 shares of the company’s stock valued at $27,000 after buying an additional 620 shares in the last quarter. Finally, University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Palantir Technologies in the second quarter valued at approximately $30,000. Institutional investors and hedge funds own 45.65% of the company’s stock.

Insider Buying and Selling

In other Palantir Technologies news, Director Lauren Elaina Friedman Stat sold 7,321 shares of the business’s stock in a transaction that occurred on Friday, October 11th. The stock was sold at an average price of $43.90, for a total value of $321,391.90. Following the transaction, the director now directly owns 138,304 shares of the company’s stock, valued at approximately $6,071,545.60. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Lauren Elaina Friedman Stat sold 7,321 shares of the stock in a transaction dated Friday, October 11th. The shares were sold at an average price of $43.90, for a total transaction of $321,391.90. Following the transaction, the director now owns 138,304 shares of the company’s stock, valued at $6,071,545.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ryan D. Taylor sold 249,684 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $30.01, for a total value of $7,493,016.84. Following the transaction, the insider now directly owns 372,565 shares in the company, valued at approximately $11,180,675.65. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,747,176 shares of company stock valued at $646,951,347 over the last 90 days. Company insiders own 12.93% of the company’s stock.

Palantir Technologies Stock Performance

NYSE:PLTR opened at $42.95 on Wednesday. Palantir Technologies Inc. has a 52 week low of $14.48 and a 52 week high of $44.39. The firm’s fifty day moving average is $35.87 and its 200-day moving average is $28.28. The firm has a market cap of $96.18 billion, a P/E ratio of 252.66 and a beta of 2.72.

Palantir Technologies (NYSE:PLTR) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Palantir Technologies had a return on equity of 8.88% and a net margin of 16.32%. The business had revenue of $678.13 million for the quarter, compared to analyst estimates of $653.23 million. During the same quarter in the previous year, the business posted $0.01 earnings per share. The business’s revenue was up 27.2% on a year-over-year basis. As a group, sell-side analysts anticipate that Palantir Technologies Inc. will post 0.19 earnings per share for the current year.

Wall Street Analyst Weigh In

PLTR has been the topic of several analyst reports. Jefferies Financial Group increased their price target on shares of Palantir Technologies from $24.00 to $28.00 and gave the stock a “hold” rating in a research report on Monday, July 29th. Citigroup upped their price objective on shares of Palantir Technologies from $25.00 to $28.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 30th. Northland Securities began coverage on Palantir Technologies in a report on Thursday, August 22nd. They set a “market perform” rating and a $35.00 price objective on the stock. Bank of America upped their target price on Palantir Technologies from $30.00 to $50.00 and gave the stock a “buy” rating in a report on Tuesday, September 10th. Finally, Northland Capmk raised Palantir Technologies to a “hold” rating in a research note on Thursday, August 22nd. Five analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Palantir Technologies currently has an average rating of “Hold” and a consensus price target of $27.86.

About Palantir Technologies

Palantir Technologies Inc builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally. The company provides Palantir Gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform.